• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素 IV 在小鼠肾脏中的血管收缩和升压反应是由 AT1a 受体介导的。

Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.

机构信息

Department of Pharmacology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090-Brussels, Belgium.

出版信息

J Hypertens. 2010 Mar;28(3):487-94. doi: 10.1097/HJH.0b013e3283343250.

DOI:10.1097/HJH.0b013e3283343250
PMID:19907343
Abstract

OBJECTIVES

Angiotensin (Ang) IV was reported to induce renal vasoconstriction or vasodilation in rats via AT1 or AT4 receptors, respectively, whereby the latter one has been identified to be the insulin-regulated aminopeptidase (IRAP). We investigated the effects of Ang IV on mean arterial pressure (MAP) and renal cortical blood flow (CBF) in AT1a, AT1b, AT2 receptor and IRAP knockout (-/-) mice and their corresponding wild-type littermates. Ang II, known as a renal vasoconstrictor in mice, was used as a reference.

METHODS

MAP was recorded via a femoral catheter and CBF was measured using a light amplification by stimulated emission of radiation (LASER) Doppler probe; cortical vascular resistance (CVR) was calculated as MAP divided by CBF.

RESULTS

Baseline MAP, CBF and CVR in AT1a (-/-) mice were significantly lower than wild-type mice. AT2 (-/-) mice had a significantly higher baseline MAP, but similar CBF. In wild-type mice, Ang IV and Ang II induced dose-dependent pressor and renal vasoconstrictor responses, which were antagonized by the AT1 receptor blocker candesartan. These responses were almost completely absent in AT1a (-/-) mice, but were enhanced in AT2 (-/-) mice; responses in AT1b (-/-) and IRAP (-/-) mice were comparable to those in corresponding wild-type mice.

CONCLUSION

Ang IV mediates pressure and renal vasoconstrictor effects in mice via AT1a receptors, whereas IRAP/AT4 is not involved.

摘要

目的

血管紧张素(Ang)IV 据报道可分别通过 AT1 或 AT4 受体诱导大鼠的肾血管收缩或舒张,其中后者已被鉴定为胰岛素调节氨基肽酶(IRAP)。我们研究了 Ang IV 对 AT1a、AT1b、AT2 受体和 IRAP 敲除(-/-)小鼠及其相应野生型同窝仔鼠的平均动脉压(MAP)和皮质肾血流量(CBF)的影响。已知 Ang II 是小鼠的肾血管收缩剂,被用作参考。

方法

通过股动脉导管记录 MAP,使用光放大受激发射(LASER)多普勒探头测量 CBF;皮质血管阻力(CVR)计算为 MAP 除以 CBF。

结果

AT1a(-/-)小鼠的基础 MAP、CBF 和 CVR 明显低于野生型小鼠。AT2(-/-)小鼠的基础 MAP 明显升高,但 CBF 相似。在野生型小鼠中,Ang IV 和 Ang II 诱导出剂量依赖性的升压和肾血管收缩反应,该反应被 AT1 受体阻滞剂坎地沙坦所拮抗。这些反应在 AT1a(-/-)小鼠中几乎完全缺失,但在 AT2(-/-)小鼠中增强;AT1b(-/-)和 IRAP(-/-)小鼠的反应与相应的野生型小鼠相似。

结论

Ang IV 通过 AT1a 受体介导小鼠的血压和肾血管收缩作用,而 IRAP/AT4 不参与该作用。

相似文献

1
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.血管紧张素 IV 在小鼠肾脏中的血管收缩和升压反应是由 AT1a 受体介导的。
J Hypertens. 2010 Mar;28(3):487-94. doi: 10.1097/HJH.0b013e3283343250.
2
Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.脑和外周血管紧张素II 1型受体介导大鼠对血管紧张素IV的肾血管收缩和血压反应。
J Hypertens. 2008 May;26(5):998-1007. doi: 10.1097/HJH.0b013e3282f5ed58.
3
Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.坎地沙坦对大鼠和小鼠体内血管紧张素II诱导的肾血管收缩的影响。
J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S202-7.
4
AT1b receptor predominantly mediates contractions in major mouse blood vessels.AT1b受体主要介导小鼠主要血管的收缩。
Circ Res. 2003 Nov 28;93(11):1089-94. doi: 10.1161/01.RES.0000101912.01071.FF. Epub 2003 Oct 16.
5
Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors.血管紧张素AT1a受体缺陷小鼠的渗透反应增强:AT1b受体作用的证据
Exp Physiol. 2005 Sep;90(5):739-46. doi: 10.1113/expphysiol.2005.030643. Epub 2005 Jun 8.
6
Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization.醛固酮通过1型血管紧张素II(AT1)受体产生的血管收缩作用:AT1受体二聚化的潜在作用
Cardiovasc Res. 2008 Jul 1;79(1):169-78. doi: 10.1093/cvr/cvn064. Epub 2008 Mar 7.
7
Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent.新型血管紧张素 A 肽的升压和肾脏血流动力学作用依赖于血管紧张素 II 型 1A 受体。
Hypertension. 2011 May;57(5):956-64. doi: 10.1161/HYPERTENSIONAHA.110.161836. Epub 2011 Apr 4.
8
Renal segmental microvascular responses to ANG II in AT1A receptor null mice.AT1A受体基因敲除小鼠肾节段性微血管对血管紧张素II的反应
Am J Physiol Renal Physiol. 2003 Mar;284(3):F538-45. doi: 10.1152/ajprenal.00340.2002. Epub 2002 Nov 12.
9
TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.TP受体在血管紧张素II缓慢升压反应过程中调节肾血流动力学。
Am J Physiol Renal Physiol. 2004 Oct;287(4):F753-9. doi: 10.1152/ajprenal.00423.2003. Epub 2004 Jun 22.
10
Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.大脑中血管紧张素IV的长期产生会导致高血压,而血管紧张素II AT1受体拮抗剂可使其逆转。
Circ Res. 2004 Jun 11;94(11):1451-7. doi: 10.1161/01.RES.0000130654.56599.40. Epub 2004 Apr 29.

引用本文的文献

1
Arterial Hypertension: Novel Pharmacological Targets and Future Perspectives.动脉高血压:新的药理学靶点与未来展望
J Clin Med. 2024 Oct 4;13(19):5927. doi: 10.3390/jcm13195927.
2
The relationship between chronic immune response and neurodegenerative damage in long COVID-19.长新冠中慢性免疫反应与神经退行性损伤的关系。
Front Immunol. 2022 Dec 16;13:1039427. doi: 10.3389/fimmu.2022.1039427. eCollection 2022.
3
Effects of angiotensin peptides on colonic motility in rats.血管紧张素肽对大鼠结肠运动的影响。
Ann Coloproctol. 2023 Jun;39(3):267-274. doi: 10.3393/ac.2022.00087.0012. Epub 2022 Mar 30.
4
Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies.治疗高血压及其相关并发症的新疗法:基于肽和非肽的策略。
Hypertens Res. 2021 Jul;44(7):740-755. doi: 10.1038/s41440-021-00643-z. Epub 2021 Mar 17.
5
Assessing Renal Microvascular Reactivity by Laser Speckle-Contrast Imaging in Angiotensin-II-Treated Mice.通过激光散斑对比成像评估血管紧张素 II 处理小鼠的肾微血管反应性。
Int J Nephrol Renovasc Dis. 2020 Mar 27;13:45-51. doi: 10.2147/IJNRD.S240147. eCollection 2020.
6
Polytropic Influence of rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension.rs2295490基因多态性对原发性高血压患者抗高血压药物反应的多向性影响
Front Pharmacol. 2019 Mar 27;10:236. doi: 10.3389/fphar.2019.00236. eCollection 2019.
7
Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.肾素-血管紧张素系统失调与心血管疾病中加压素能系统相互作用。
Curr Hypertens Rep. 2018 Mar 19;20(3):19. doi: 10.1007/s11906-018-0823-9.
8
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?肾素-血管紧张素系统的生化评估:益处、弊端与绝对因素?
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H137-52. doi: 10.1152/ajpheart.00618.2015. Epub 2015 Oct 16.
9
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].国际基础与临床药理学联合会。XCIX. 血管紧张素受体:病理生理血管紧张素能刺激的解读器[校正后]
Pharmacol Rev. 2015 Oct;67(4):754-819. doi: 10.1124/pr.114.010454.
10
Renin-angiotensin system in the kidney: What is new?肾脏中的肾素-血管紧张素系统:有哪些新进展?
World J Nephrol. 2014 Aug 6;3(3):64-76. doi: 10.5527/wjn.v3.i3.64.